started · updated
South Koreans travel to Japan for cheaper obesity drugs
A growing number of South Koreans are traveling to Japan to purchase obesity treatments such as Mounjaro and Wegovy due to significant price differences. Following a recent decision by the South Korean Ministry of Food and Drug Safety to allow the importation of up to three months of self-treatment medicines prescribed abroad, many travelers are opting for Japanese clinics.
In Japan, the cost of Mounjaro is approximately one-fourth of the price in South Korea, where the drugs are classified as non-reimbursable items with varying costs. This price gap, combined with a weak Japanese yen and the availability of telemedicine services in Japanese clinics that offer delivery to hotels, has fueled the trend. Some travelers are even planning short trips to cities like Fukuoka or Osaka to receive prescriptions and return home quickly.
However, officials have raised concerns regarding the sudden policy change. While the move aims to accommodate patient convenience, there are fears it could increase illegal smuggling via international mail. Additionally, medical experts warn of potential safety risks and side effects associated with obtaining medications through unregulated or non-traditional channels.
Entities
Japan · Ministry of Food and Drug Safety · Mounjaro · South Korea · Wegovy